Extracellular matrix composition modulates angiosarcoma cell attachment and proliferation.

about

Extracellular matrix composition modulates angiosarcoma cell attachment and proliferation.

Item

http://www.wikidata.org/entity/Q49201192

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Extracellular matrix compositi ...... attachment and proliferation.

@en

Extracellular matrix compositi ...... attachment and proliferation.

@nl

type

Item

label

Extracellular matrix compositi ...... attachment and proliferation.

@en

Extracellular matrix compositi ...... attachment and proliferation.

@nl

prefLabel

Extracellular matrix compositi ...... attachment and proliferation.

@en

Extracellular matrix compositi ...... attachment and proliferation.

@nl

P1476

Extracellular matrix compositi ...... attachment and proliferation.

@en

P2093

Brad A Bryan

http://www.w3.org/2001/XMLSchema#string

Dana Galvan

http://www.w3.org/2001/XMLSchema#string

Esha Kataria

http://www.w3.org/2001/XMLSchema#string

Jocelyn Antony

http://www.w3.org/2001/XMLSchema#string

Noel L Shaheen

http://www.w3.org/2001/XMLSchema#string

Yessenia Ballou

http://www.w3.org/2001/XMLSchema#string

P2860

PDK1, the master regulator of AGC kinase signal transduction

Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study.

Interleukin-8 promotes canine hemangiosarcoma growth by regulating the tumor microenvironment.

Overexpression of VEGF 121 in immortalized endothelial cells causes conversion to slowly growing angiosarcoma and high level expression of the VEGF receptors VEGFR-1 and VEGFR-2 in vivo.

Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways.

Gene expression analysis reveals marked differences in the transcriptome of infantile hemangioma endothelial cells compared to normal dermal microvascular endothelial cells.

Angiosarcoma outcomes and prognostic factors: a 25-year single institution experience.

Phase II study of sorafenib in patients with metastatic or recurrent sarcomas.

PDK1: A signaling hub for cell migration and tumor invasion.

Integrin-mediated signaling events in human endothelial cells.

P304

178-188

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOSCIENCE.383

http://www.w3.org/2001/XMLSchema#string

P433

11-12

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29344556

http://www.w3.org/2001/XMLSchema#string

P932

5769982

http://www.w3.org/2001/XMLSchema#string